<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01518023</url>
  </required_header>
  <id_info>
    <org_study_id>Lessdiabetes</org_study_id>
    <nct_id>NCT01518023</nct_id>
  </id_info>
  <brief_title>Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy</brief_title>
  <official_title>Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is evidence that gastrointestinal operations for non weight-losing purposes are
      beneficial for diabetes mellitus. Aiming to analyze such hypothesis, patients submitted to
      gastric bypass for morbid obesity, gastrectomy for gastric cancer and colectomy for
      colo-rectal cancer will be compared. The end point will be changes in fasting blood glucose
      and hemoglobin A1c concentration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a prospective protocol with retrospective information, patients (N=240) undergoing
      bariatric Roux-en-Y gastric bypass (n=80), cancer subtotal or total gastrectomy (n=80) and
      right colectomy or rectosigmoidectomy (n=80) with follow-up &gt;3 years free of disease, with or
      without previously impaired fasting blood glucose, will be recruited. Patients will be
      submitted to a questionnaire involving diet, diagnosis of diabetes and glucose-lowering
      drugs, body weight and other clinical items. Preoperative information available in the
      hospital system will be completed and current findings will be updated, including body mass
      index and biochemical measurements. Using the outcomes of the bariatric population as
      benchmark, both concerning diabetics that were ameliorated and nondiabetics that progressed
      to new-onset diabetes,results in the other groups will be compared. The study should answer
      whether gastric and colorectal surgery for cancer 1) Are beneficial for established diabetes;
      2) Attenuate the conversion of normal patients to diabetes, both within a follow-up period of
      3- 12 years;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fasting blood glucose</measure>
    <time_frame>3-12 years change</time_frame>
    <description>Glucose improvement or deterioration comparing preoperative versus late postoperative value. Classification according to the American Diabetes Association</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HbA1c</measure>
    <time_frame>3-12 years</time_frame>
    <description>Same as fasting blood glucose (preoperative versus current change). Classification according to the American Diabetes Association.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">240</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Prediabetes</condition>
  <condition>Morbid Obesity</condition>
  <condition>Gastric Cancer</condition>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Cancer gastrectomy</arm_group_label>
    <description>Patients previously submitted to partial/total gastrectomy for gastric cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Colorectal cancer operation</arm_group_label>
    <description>Patients previously submitted to right colectomy or rectosignoidectomy for cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bariatric patients</arm_group_label>
    <description>Morbidly obese participants who underwent antiobesity Roux-en-Y gastric bypass</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Interview, questionnaire, updated biochemical tests</intervention_name>
    <description>Patients will be interviewed and questioned about nutritional status, diet, drugs and diagnosis/clinical course of diabetes. Routine biochemical tests will be searched and if necessary updated.</description>
    <arm_group_label>Cancer gastrectomy</arm_group_label>
    <arm_group_label>Colorectal cancer operation</arm_group_label>
    <arm_group_label>Bariatric patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult males and females submitted to elective curative operations will be enrolled
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Follow-up period &gt; 3 years,

          -  weight stable in the last year

        Exclusion Criteria:

          -  Reoperation or take-down of original operation,

          -  consumptive diseases,

          -  protein-calorie malnutrition,

          -  organ failures,

          -  pancreatic surgery,

          -  cell or organ transplantation,

          -  type 1 diabetes,

          -  cognitive impairment or Alzheimer disease,

          -  refusal to participate in the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joel Faintuch, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital das Clinicas, Sao Paulo, Brazil</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital das Clinicas- Central Institute ICHC- 9th Floor Rm 9077</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Faintuch J, Yamaguchi CM, Dias MC, Santo MA, Faintuch JJ, Cecconello I. Biochemical correlates of bariatric-responsive diabetes. Diabetes Technol Ther. 2010 Sep;12(9):707-15. doi: 10.1089/dia.2010.0018.</citation>
    <PMID>20707737</PMID>
  </reference>
  <reference>
    <citation>Kim JW, Cheong JH, Hyung WJ, Choi SH, Noh SH. Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol. 2012 Jan 7;18(1):49-54. doi: 10.3748/wjg.v18.i1.49.</citation>
    <PMID>22228970</PMID>
  </reference>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2012</study_first_submitted>
  <study_first_submitted_qc>January 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2012</study_first_posted>
  <last_update_submitted>January 24, 2012</last_update_submitted>
  <last_update_submitted_qc>January 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Joel Faintuch</investigator_full_name>
    <investigator_title>Associate Professor, Department of Gastroenterology</investigator_title>
  </responsible_party>
  <keyword>diabetes mellitus</keyword>
  <keyword>prediabetes</keyword>
  <keyword>fasting blood glucose</keyword>
  <keyword>HbA1c</keyword>
  <keyword>Roux en Y gastric bypass</keyword>
  <keyword>Cancer gastrectomy</keyword>
  <keyword>Cancer colorectal surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

